<DOC>
	<DOC>NCT00801710</DOC>
	<brief_summary>This study is to determine if the BridgePoint Medical System (CrossBoss Catheter, Stingray Catheter, Entera Guidewire) can facilitate safe and effective placement of a guidewire in the true lumen of coronary vessels distal to a chronic total occlusion (CTO). The hypothesis is that the BridgePoint Medical System can do this without an increase in major complications.</brief_summary>
	<brief_title>CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Suitable for coronary intervention de novo or restenotic CTO at least 3 months old, in proximal or mid coronary artery segment, 3.05.0 mm in diameter Mild/moderate proximal vessel tortuosity Mild/moderate lesion angulation Mild/moderate calcification Satisfactory distal vessel visualization Mild/moderate side branch interference 19 years old BMI&lt;40 LVEF&gt;20% Signed informed consent Extensive dissection from guidewire manipulation SVG or instent CTO Aortoostial CTO Unable to take aspirin, Clopidogrel, or Ticlopidine Thrombus/vessel filling defects Severe cerebrovascular disease/stroke within 1 month Intervention within 2 weeks Renal insufficiency GI bleeding Active infection Life expectancy &lt;2 years Significant anemia Uncontrolled hypertension Severe electrolyte imbalance Anaphylaxis to contrast NYHA class IV Unstable angina requiring intervention MI within 2 weeks Uncontrolled diabetes Participating in another protocol Unwilling/unable to comply with protocol Angina/ischemia caused by target vessel</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>